The use of nonsteroidal anti-inflammatory drugs after sleeve gastrectomy

Background: The use of nonsteroidal anti-inflammatory drugs (NSAIDs) is discouraged after bariatric surgery. The effect of NSAIDs on patients who have undergone sleeve gastrectomy (SG) is not well studied. Moreover, the rate of NSAID use after SG is unknown. Objectives: To determine the rate of NSAID use after SG, and its associated complications. Setting: A single institution, multi-surgeon, academic, tertiary care hospital. Methods: We performed a retrospective review of patients who underwent SG between January 1, 2014, and November 1, 2017. A phone interview was conducted with identified patients. The inclusion criteria were any patient who had undergone SG during the study period, and there were no exclusion criteria. Results: We identified 421 SG patients for inclusion. There were 231 phone surveys completed, with 64.5% of respondents reporting some NSAID use after SG. Of the respondents who used NSAIDs, 40.3% reported that they used the drugs often (>once/wk), 28.2% reported occasional use (>once/mo but,once/wk), and 31.5% reported rare use (

Automated summary

This study aimed to investigate the rate of NSAID use and associated complications in patients who underwent sleeve gastrectomy (SG). The findings revealed that a significant proportion of patients continued to use NSAIDs after SG, with some using them frequently. These results highlight the potential risks of NSAID use in SG patients, suggesting a need for caution among healthcare providers.